STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies
STAT News · LC · trust 52/100
An experimental COPD drug from AstraZeneca could prove competitive with existing treatments, and have a slice of the market to itself.
Read the original at STAT News →
Open in TruthVane →